Log in to save to my catalogue

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertens...

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertens...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb619c93354049828bc8e360f53f0407

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients

About this item

Full title

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients

Publisher

London, England: SAGE Publications

Journal title

Pulmonary circulation, 2021-10, Vol.11 (4), p.1-4

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Hyperventilation is common in pulmonary arterial hypertension and may be related to autonomic imbalance. Patients underwent exercise testing and hyperoxic breathing before and after bisoprolol treatment. We found that neither beta blocker treatment nor hyperoxic breathing in patients reduced hyperventilation at rest and during exercise, although it...

Alternative Titles

Full title

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fb619c93354049828bc8e360f53f0407

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb619c93354049828bc8e360f53f0407

Other Identifiers

ISSN

2045-8940,2045-8932

E-ISSN

2045-8940

DOI

10.1177/20458940211057890

How to access this item